24 related articles for article (PubMed ID: 33320604)
1. Exploring the synergistic behavior of paclitaxel and vorinostat upon co-loading in albumin nanoparticles for breast cancer management.
Abhang A; Katari O; Ghadi R; Chaudhari D; Jain S
Drug Deliv Transl Res; 2024 Feb; 14(2):510-523. PubMed ID: 37605040
[TBL] [Abstract][Full Text] [Related]
2. Formulation development, stability and anticancer efficacy of core-shell cyclodextrin nanocapsules for oral chemotherapy with camptothecin.
Ünal H; Öztürk N; Bilensoy E
Beilstein J Org Chem; 2015; 11():204-12. PubMed ID: 25815071
[TBL] [Abstract][Full Text] [Related]
3. The novel rexinoid MSU-42011 is effective for the treatment of preclinical Kras-driven lung cancer.
Moerland JA; Zhang D; Reich LA; Carapellucci S; Lockwood B; Leal AS; Krieger-Burke T; Aleiwi B; Ellsworth E; Liby KT
Sci Rep; 2020 Dec; 10(1):22244. PubMed ID: 33335263
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival and response to tepotinib in a non-small-cell lung cancer patient with brain metastases harboring
Roth KG; Mambetsariev I; Salgia R
Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33335011
[TBL] [Abstract][Full Text] [Related]
5. Non-Steroidal Anti-Inflammatory Drugs Increase Cisplatin, Paclitaxel, and Doxorubicin Efficacy against Human Cervix Cancer Cells.
Robledo-Cadena DX; Gallardo-Pérez JC; Dávila-Borja V; Pacheco-Velázquez SC; Belmont-Díaz JA; Ralph SJ; Blanco-Carpintero BA; Moreno-Sánchez R; Rodríguez-Enríquez S
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33333716
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative drug-loaded multi-functionalized intraocular lens for reducing posterior capsular opacification.
Huang H; Zhu S; Liu D; Wen S; Lin Q
J Biomater Sci Polym Ed; 2021 Apr; 32(6):735-748. PubMed ID: 33332253
[TBL] [Abstract][Full Text] [Related]
7. GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer.
Ferracini AC; Lopes-Aguiar L; Lourenço GJ; Yoshida A; Lima CSP; Sarian LO; Derchain S; Kroetz DL; Mazzola PG
Clin Transl Sci; 2021 Mar; 14(2):720-728. PubMed ID: 33326171
[TBL] [Abstract][Full Text] [Related]
8. Temperature and Photo Dual-Stimuli Responsive Block Copolymer Self-Assembly Micelles for Cellular Controlled Drug Release.
Zhou ZH; Zhang JG; Chen Q; Luo YL; Xu F; Chen YS
Macromol Biosci; 2021 Mar; 21(3):e2000291. PubMed ID: 33326167
[TBL] [Abstract][Full Text] [Related]
9. Core-Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems.
Mehandole A; Walke N; Mahajan S; Aalhate M; Maji I; Gupta U; Mehra NK; Singh PK
AAPS PharmSciTech; 2023 Jan; 24(1):50. PubMed ID: 36703085
[TBL] [Abstract][Full Text] [Related]
10. Lipid and Biosurfactant Based Core-Shell-Type Nanocapsules Having High Drug Loading of Paclitaxel for Improved Breast Cancer Therapy.
Katiyar SS; Ghadi R; Kushwah V; Dora CP; Jain S
ACS Biomater Sci Eng; 2020 Dec; 6(12):6760-6769. PubMed ID: 33320604
[TBL] [Abstract][Full Text] [Related]
11. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of cellular uptake and cytotoxicity of paclitaxel loaded lipid nanocapsules in breast cancer cells.
Valsalakumari R; Yadava SK; Szwed M; Pandya AD; Mælandsmo GM; Torgersen ML; Iversen TG; Skotland T; Sandvig K; Giri J
Int J Pharm; 2021 Mar; 597():120217. PubMed ID: 33486035
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel loaded fibrinogen coated CdTe/ZnTe core shell nanoparticles for targeted imaging and drug delivery to breast cancer cells.
Rejinold NS; Baby T; Nair SV; Jayakumar R
J Biomed Nanotechnol; 2013 Oct; 9(10):1657-71. PubMed ID: 24015495
[TBL] [Abstract][Full Text] [Related]
14. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate.
Katiyar SS; Kushwah V; Dora CP; Jain S
Int J Pharm; 2019 Feb; 557():86-96. PubMed ID: 30584909
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
